NCT00492479

Brief Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jun 2007

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

June 25, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 27, 2007

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

December 24, 2007

Status Verified

December 1, 2007

First QC Date

June 25, 2007

Last Update Submit

December 18, 2007

Conditions

Skin Aging

Interventions

Kinerase Pro+Therapy Line day repair, serum, night repairDRUG
Kinerase Pro+Therapy Line Ultra rich day repairDRUG
LubriDermDRUG

Eligibility Criteria

Age35 Years - 55 Years
Sexfemale
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients 35-55 years of age with at least moderate signs of facial aging
  • Written informed consent
  • Likely to complete all study visits and follow study protocol

You may not qualify if:

  • Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
  • Known hypersensitivity to any study product or their components
  • Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
  • Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
  • Planned facial procedures during the study (microdermabrasion, facials, etc)
  • o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
  • Recent (within 60 days) or concurrent participation in another clinical trial
  • Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
  • Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
  • Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
  • Wearing of cosmetics during study visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Steve Yoelin MD practice

Santa Ana, California, 92701, United States

Location

Study Officials

  • Steven Yoelin, MD

    Private Practice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 25, 2007

First Posted

June 27, 2007

Study Start

June 1, 2007

Study Completion

December 1, 2007

Last Updated

December 24, 2007

Record last verified: 2007-12

Locations

US(1)